Published in Int J Cancer on January 30, 1998
Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology (2012) 10.00
Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol (2008) 3.34
The natural history of hepatitis C virus (HCV) infection. Int J Med Sci (2006) 3.13
Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol (2013) 3.12
The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis (2010) 2.96
The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol (2008) 2.02
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology (2009) 1.80
A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer (2005) 1.76
Viral hepatocarcinogenesis. Oncogene (2010) 1.73
Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med (2012) 1.71
Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS (2009) 1.64
Retracted Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J Biol Chem (2009) 1.56
Diagnosis of hepatocellular carcinoma. HPB (Oxford) (2005) 1.43
Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. Hepatology (2007) 1.40
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. World J Gastrointest Oncol (2010) 1.36
Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol (2005) 1.35
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines. Can J Gastroenterol (2012) 1.27
Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol (2011) 1.26
The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat (2008) 1.22
Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol (2005) 1.22
Oncogenic potential of hepatitis C virus proteins. Viruses (2010) 1.22
Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci (2009) 1.17
Natural history of chronic hepatitis B - clinical implications. Medscape J Med (2008) 1.13
Hepatitis C virus infection, Linxian, China. Emerg Infect Dis (2005) 1.10
Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J Cancer Res Clin Oncol (2003) 1.09
Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Hepatology (2007) 1.08
Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma. Int J Clin Oncol (2012) 1.08
Hepatocellular carcinoma in the world and the middle East. Middle East J Dig Dis (2010) 1.07
Cluster of liver cancer and immigration: a geographic analysis of incidence data for Ontario 1998-2002. Int J Health Geogr (2008) 1.04
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol (2006) 0.97
Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States. J Subst Abuse Treat (2011) 0.96
Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea. Br J Cancer (2010) 0.95
Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony. Curr Hepat Rep (2010) 0.95
Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma. Free Radic Biol Med (2014) 0.94
11. Cancers attributable to infection in the UK in 2010. Br J Cancer (2011) 0.93
Recent developments in the first detection of hepatocellular carcinoma. Clin Biochem Rev (2005) 0.93
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India. J Clin Exp Hepatol (2014) 0.90
The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy. Am J Pathol (2013) 0.89
The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis. Virol J (2012) 0.88
Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis. PLoS One (2013) 0.88
Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med (2015) 0.87
Production and pathogenicity of hepatitis C virus core gene products. World J Gastroenterol (2014) 0.85
Dual chronic hepatitis B virus and hepatitis C virus infection. Hepatol Int (2009) 0.85
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015. J Clin Exp Hepatol (2015) 0.85
Hepatitis B virus and hepatitis C virus dual infection. World J Gastroenterol (2014) 0.84
Fifteen-year population attributable fractions and causal pies of risk factors for newly developed hepatocellular carcinomas in 11,801 men in Taiwan. PLoS One (2012) 0.83
Influence of occult hepatitis B virus infection in chronic hepatitis C outcomes. World J Gastroenterol (2011) 0.83
Hepatocellular carcinoma in pakistan: where do we stand? Hepat Mon (2012) 0.83
Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma. Curr Genomics (2014) 0.82
Viral carcinogenesis: factors inducing DNA damage and virus integration. Cancers (Basel) (2014) 0.82
Early-life exposures to infectious agents and later cancer development. Cancer Med (2015) 0.82
Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus. Korean J Hepatol (2011) 0.81
Oxidative stress-induced 1, N6-ethenodeoxyadenosine adduct formation contributes to hepatocarcinogenesis. Oncol Rep (2013) 0.81
Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience. HPB (Oxford) (2013) 0.80
Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study. BMC Cancer (2012) 0.80
Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies. BMC Gastroenterol (2013) 0.80
Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine. EPMA J (2014) 0.80
Hepatitis B vaccinations among Koreans: Results from 2005 Korea National Cancer Screening Survey. BMC Infect Dis (2009) 0.80
Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol (2016) 0.80
Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma. BMC Cancer (2010) 0.79
Hepatitis B virus X upregulates HuR protein level to stabilize HER2 expression in hepatocellular carcinoma cells. Biomed Res Int (2014) 0.79
The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management. Ann Gastroenterol (2015) 0.79
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses. PLoS One (2011) 0.79
Rising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005). World J Gastroenterol (2007) 0.79
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. Hepatol Int (2016) 0.79
Risk Factors for the Development of Hepatocellular Carcinoma in Thailand. J Clin Transl Hepatol (2015) 0.78
Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma. PLoS One (2013) 0.78
Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus. Hepat Med (2011) 0.78
Significance of prior hepatitis B virus infection in the development of hepatocellular carcinoma in patients with chronic hepatitis C. Dig Dis Sci (2003) 0.77
Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev (2013) 0.77
[Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology]. Pathologe (2007) 0.77
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int (2017) 0.77
Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues. World J Gastroenterol (2007) 0.76
Biological impact of hepatitis B virus X-hepatitis C virus core fusion gene on human hepatocytes. World J Gastroenterol (2008) 0.76
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. World J Hepatol (2014) 0.76
Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection. World J Gastroenterol (2014) 0.76
Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan. BMC Cancer (2016) 0.75
Anti-androgen resistance in prostate cancer cells chronically induced by interleukin-1β. Am J Clin Exp Urol (2013) 0.75
A review of the infection-associated cancers in North African countries. Infect Agent Cancer (2016) 0.75
Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis. Visc Med (2016) 0.75
Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study. Epidemiol Infect (2006) 0.75
MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin. Sci Rep (2016) 0.75
Sex differences associated with hepatitis B virus surface antigen seropositivity unwareness in hepatitis B virus surface antigen-positive adults: 2007-2012 Korea National Health and Nutrition Examination Survey. J Prev Med Public Health (2015) 0.75
Relationship between HLA-DRB1 allele polymorphisms and familial aggregations of hepatocellular carcinoma. Curr Oncol (2016) 0.75
Towards the elimination and eradication of hepatitis B. J Virus Erad (2015) 0.75
Profound jaundice in a patient with acute hepatitis C. BMJ Case Rep (2013) 0.75
Association between extranodal natural killer/T-cell lymphoma and hepatitis B viral infection: a case-control study. J Cancer (2017) 0.75
Clinical characteristics of hepatitis B core antibody-positive hepatocellular carcinoma. World J Surg (2002) 0.75
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Pooled exposure-response analyses and risk assessment for lung cancer in 10 cohorts of silica-exposed workers: an IARC multicentre study. Cancer Causes Control (2001) 3.74
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. Aliment Pharmacol Ther (2011) 3.10
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol (2002) 2.94
Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer (2008) 2.79
Exposure-response analysis and risk assessment for silica and silicosis mortality in a pooled analysis of six cohorts. Occup Environ Med (2002) 2.70
Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ (1997) 2.64
Occupational exposure to carcinogens in the European Union. Occup Environ Med (2000) 2.18
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer (2000) 2.16
Alcohol drinking and cutaneous melanoma risk: a systematic review and dose-risk meta-analysis. Br J Dermatol (2014) 2.15
Pleural mesothelioma and asbestos exposure among Italian oil refinery workers. Scand J Work Environ Health (1994) 2.06
Light alcohol drinking and cancer: a meta-analysis. Ann Oncol (2012) 2.04
Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr (2006) 2.03
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 2.02
Attributable causes of cancer in China. Ann Oncol (2012) 1.98
Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences. Science (1991) 1.92
Tobacco use and cancer causation: association by tumour type. J Intern Med (2002) 1.91
Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst (1992) 1.88
Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer (1993) 1.86
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med (2008) 1.84
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol (2011) 1.84
Non-neoplastic mortality of European workers who produce man made vitreous fibres. Occup Environ Med (1999) 1.83
Cancer risk in the rubber industry: a review of the recent epidemiological evidence. Occup Environ Med (1998) 1.79
Limitations of biomarkers of exposure in cancer epidemiology. Epidemiology (1995) 1.76
Classic kaposi sarcoma: epidemiology and risk factors. Cancer (2000) 1.74
Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis (2007) 1.73
Population attributable fraction of infection-related cancers in Korea. Ann Oncol (2010) 1.72
Epidemiology of bladder cancer in Alexandria, Egypt: tobacco smoking. Int J Cancer (1997) 1.71
Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer (1988) 1.69
Tobacco use, cancer causation and public health impact. J Intern Med (2002) 1.64
A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol (2011) 1.62
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. Br J Haematol (2001) 1.62
Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer (1997) 1.60
Avoided and avoidable risks of cancer. Carcinogenesis (1997) 1.58
Weight change in later life and risk of death amongst the elderly: the European Prospective Investigation into Cancer and Nutrition-Elderly Network on Ageing and Health study. J Intern Med (2010) 1.58
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann Oncol (2011) 1.57
Risk factors of lung cancer in Chandigarh, India. Indian J Med Res (2001) 1.57
Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56
Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer (2005) 1.54
Role of tobacco and alcoholic beverages in the etiology of cancer of the oral cavity/oropharynx in Torino, Italy. Cancer Res (1989) 1.53
Lead and cancer in humans: where are we now? Am J Ind Med (2000) 1.51
Exposure to environmental tobacco smoke and risk of lung cancer: the epidemiological evidence. Eur Respir J (1994) 1.48
Second follow-up of a Dutch cohort occupationally exposed to phenoxy herbicides, chlorophenols, and contaminants. Am J Epidemiol (1998) 1.46
Research on cancer prevention, detection and management in low- and medium-income countries. Ann Oncol (2010) 1.45
Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Eur J Epidemiol (2000) 1.44
Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation. J Med Genet (2005) 1.44
Smoking habits of 800,000 American men and women in relation to their occupations. Am J Ind Med (1988) 1.41
Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer (2001) 1.40
Environmental risk factors of breast cancer. Scand J Work Environ Health (1998) 1.40
The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control (2001) 1.40
Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup Environ Med (1995) 1.39
Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health (1998) 1.38
Are evaluations of carcinogenicity by various committees worth comparing? Med Lav (1994) 1.37
Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005. Ann Oncol (2006) 1.36
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol (2011) 1.36
Detection of clonal T cell populations with closely related T cell receptor junctional sequences in persons at high risk for human immunodeficiency virus (HIV) infection and in patients acutely infected with HIV. J Infect Dis (1997) 1.35
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35
Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br J Cancer (2011) 1.35
The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer (2004) 1.34
Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ Health Perspect (1998) 1.32
Conformity to traditional Mediterranean diet and cancer incidence: the Greek EPIC cohort. Br J Cancer (2008) 1.32
Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology (1997) 1.31
Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol (1995) 1.30
Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.29
Empirical Bayes adjustments for multiple results in hypothesis-generating or surveillance studies. Cancer Epidemiol Biomarkers Prev (2000) 1.27
Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res (2006) 1.27
Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res (2001) 1.21
Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res (2000) 1.21
Statistical modelling of the determinants of historical exposure to bitumen and polycyclic aromatic hydrocarbons among paving workers. Ann Occup Hyg (2000) 1.21
A multicenter case-control study of diet and lung cancer among non-smokers. Cancer Causes Control (2000) 1.20
Tobacco smoking, body mass index, hypertension, and kidney cancer risk in central and eastern Europe. Br J Cancer (2008) 1.20
Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India. Br J Cancer (2012) 1.17
Today's lifestyles, tomorrow's cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol (2011) 1.17
Estimating the asbestos-related lung cancer burden from mesothelioma mortality. Br J Cancer (2012) 1.17
Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer. Scand J Work Environ Health (1994) 1.14
Exposure to passive smoking during pregnancy and childhood, and cancer risk: the epidemiological evidence. Paediatr Perinat Epidemiol (1994) 1.14
Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study. Occup Environ Med (2010) 1.13
Epidemiology of occupational and environmental risk factors related to ovarian cancer. Scand J Work Environ Health (1998) 1.12
Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study. AIDS (1998) 1.12
Anthropometric factors and breast cancer risk among urban and rural women in South India: a multicentric case-control study. Br J Cancer (2008) 1.11
Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study. Int J Cancer (1999) 1.10
Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.10
Cigar, pipe, and cigarette smoking and bladder cancer risk in European men. Cancer Causes Control (2001) 1.10
Mortality in New Zealand workers exposed to phenoxy herbicides and dioxins. Occup Environ Med (2005) 1.10
Vegetables, fruits, and related nutrients and risk of breast cancer: a case-control study in Uruguay. Nutr Cancer (1999) 1.09
Metabolic syndrome and hepatocellular carcinoma risk. Br J Cancer (2012) 1.09
Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev (2000) 1.09
The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index. Br J Dermatol (2007) 1.07
Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms. Carcinogenesis (2008) 1.06
Modified Mediterranean diet and survival after myocardial infarction: the EPIC-Elderly study. Eur J Epidemiol (2007) 1.06
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe. Cancer Lett (2010) 1.05
Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis (2007) 1.05
Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. Nutr Cancer (1999) 1.04
Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer (2005) 1.04
Projections of alcohol- and tobacco-related cancer mortality in Central Europe. Int J Cancer (2000) 1.04
Securing the data economy: translating privacy and enacting security in the development of DataSHIELD. Public Health Genomics (2012) 1.04
Update of the follow-up of mortality and cancer incidence among European workers employed in the vinyl chloride industry. Epidemiology (2001) 1.03